DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: CONCLUSION: High-density SNP-array platforms with low reporting thresholds may incidentally detect a subset of exon-level copy number variations involving the DMD gene during routine prenatal testing and thereby contribute to early recognition of potential dystrophinopathy-related variants.